Proteolysis-targeting vaccines (PROTAVs) for robust combination immunotherapy of melanoma.
Wang Q, Su T, Cheng F, Zhou S, Liu X, Wang M, Xu Y, Tang R, Liao S, Dailey J, Xiao G, Yang C, Wen H, Zheng W, Wen B, Tyc KM, Liu J, Sun D, Wang S, Zhu G.
Wang Q, et al. Among authors: zhou s.
bioRxiv [Preprint]. 2024 Nov 4:2024.10.01.616069. doi: 10.1101/2024.10.01.616069.
bioRxiv. 2024.
PMID: 39574605
Free PMC article.
Preprint.